Introduction
For monitoring glycemic control in diabetes mellitus (DM), serum glycated albumin (GA, representing glycemic control over the preceding 2-3 weeks) has recently been used in addition to glycated hemoglobin (HbA1c, control over the preceding 2-3 months) [1] . GA has been shown to be a better measure than HbA1c in patients with short-term glycemic variations [1] . The GA/HbA1c ratio may be useful in patients with glycemic variations and the ratio was indeed higher in type 1 DM (T1DM) patients (who are prone to show instable glycemic behaviors due to the lack of intrinsic insulin secretion) than those with type 2 DM (T2DM) [2] . Establishing clinical indications for GA/HbA1c ratio is necessary.
While abnormal erythrocyte conditions affect HbA1c measurement, GA can be influenced by abnormal albumin turnover conditions [3] . Further clarification of factors affecting GA is required to use the GA/HbA1c ratio appropriately. Men with normal glucose tolerance have been reported to have lower GA levels in smokers than nonsmokers [4] . Hence, we studied the association between the GA/HbA1c ratio and smoking among T1DM patients. 
Subjects and Methods
We studied 81 cardiovascular disease-free T1DM patients (49 females, 32 males, mean age 48 8 18 years). Eligibility criteria included absence of the acute phase of ketosis and hypoglycemia, use of insulin only therapy, and absence of conditions affecting albumin/erythrocyte turnover of severe liver disease, renal disorder, thyroid disease, anemia, malnutrition, malignancy, pregnancy and steroid therapy. In addition to body mass index (BMI) and fasting plasma glucose, GA and HbA1c were measured using an enzymatic method (Asahi Kasei Pharma, Tokyo, Japan) and a HPLC method, respectively. Smoking habits were confirmed via self-reports. The study was approved by the Institutional Review Board for Human Investigation.
Data were compared between smokers and nonsmokers using Student's t test, Mann-Whitney test or 2 test. Data were presented as the mean 8 SD, median (interquartile range) for nonparametric variables, GA and HbA1c or number (percentage) of subjects. In confounders-adjusted comparisons, a general linear model was used. p ! 0.05 was considered significant.
Results
The patients' data are listed in table 1 . Nonsignificant differences were seen in the levels of GA and HbA1c alone between smokers and nonsmokers. However, smokers had significantly lower levels of the GA/HbA1c ratio than nonsmokers. This difference remained unchanged after adjusting for age and sex (p = 0.033) as well as age, sex and BMI (p = 0.046).
Discussion
Smoking habits may affect the GA/HbA1c ratio in T1DM patients, in whom the evaluation of delicate glycemic trends by markers such as GA/HbA1c ratio is often needed. This finding is noteworthy in regard to clinical application of this index.
There are several possible mechanisms for the smoking effect on the GA/HbA1c ratio in T1DM. General consensus has not necessarily been reached on the notion that smoking itself can directly worsen glycemic control, although the descriptions regarding their significant association exist [4] . Additionally, low GA in smokers has been demonstrated to be independent of glucose tolerance [4] . In our study, smoking did not statistically significantly affect fasting plasma glucose, GA and HbA1c levels. Even if smoking could worsen glycemic control, the contribution of smoking to glycemic control might not largely occur in T1DM where glycemic control often remains difficult to achieve under insulin therapy. Another considered fact is that habitual smoking leads to chronic inflammation and obesity (central obesity in particular) [5] . Whereas chronic inflammation may promote worsening glycemic control by HbA1c [6] , it facilitates albumin turnover, leading to lower GA [4, 7] . Although obesity promotes worsening glycemic control by HbA1c, it also increases albumin turnover [3, 7] . Even though BMI does not always reflect central adiposity, BMI was actually reported to inversely correlate with GA/HbA1c ratio [1, 3] , due to the effects of obesity itself and/or obesity-induced chronic inflammation on albumin [3, 7] . There was a nonsignificant difference in BMI between smokers and nonsmokers among our subjects, and the difference in GA/HbA1c ratio between smokers and nonsmokers was independent of BMI. The mean BMI of this population was under 30 with a fairly narrow range, and the independency of BMI seemed partly due to the nature of T1DM in which obesity/insulin resistance is not necessarily a primary characteristic in contrast to T2DM. This speculation is consistent with a prior report [2] . It is likely that smoking-induced chronic inflammatory reactions are more important than obesityrelated mechanism in lowering GA/HbA1c ratio among smokers with T1DM.
Conclusion
Our data show that smoking may affect GA/HbA1c ratio more than GA and HbA1c as independent factors.
